ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MIST Milestone Pharmaceuticals Inc

1.41
-0.02 (-1.40%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 81,608
Bid Price 1.31
Ask Price 4.92
News -
Day High 1.4366

Low
1.33

52 Week Range

High
3.95

Day Low 1.36
Share Name Share Symbol Market Stock Type
Milestone Pharmaceuticals Inc MIST NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.02 -1.40% 1.41 23:00:03
Open Price Low Price High Price Close Price Previous Close
1.43 1.36 1.4366 1.41 1.43
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
400 81,608 US$ 1.39 US$ 113,567 - 1.33 - 3.95
Last Trade Type Quantity Price Currency
15:00:00 274 US$ 1.41 USD

Milestone Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
46.88M 33.48M - 1M -59.69M -1.78 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Milestone Pharmaceuticals News

Date Time Source News Article
5/29/202406:09Edgar (US Regulatory)Form 8-K - Current report
5/22/202407:00GlobeNewswire Inc.Milestone Pharmaceuticals Partners with Arrhythmia Alliance..
5/13/202406:34Edgar (US Regulatory)Form 8-K - Current report
5/13/202405:59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
3/04/202408:00Edgar (US Regulatory)Form 8-K - Current report
3/01/202415:52Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
2/29/202406:00GlobeNewswire Inc.Milestone Pharmaceuticals Announces Pricing of $30.0 Million..
2/28/202415:37GlobeNewswire Inc.Milestone Pharmaceuticals Announces Proposed Public Offering..
2/26/202406:06Edgar (US Regulatory)Form 8-K - Current report
2/14/202419:56Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202406:10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
12/26/202307:54Dow Jones NewsMilestone Pharmaceuticals Shares Sink 24% After Receiving..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No MIST Message Board. Create One! See More Posts on MIST Message Board See More Message Board Posts

Historical MIST Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.48061.48061.361.45108,330-0.0706-4.77%
1 Month1.751.781.361.60230,140-0.34-19.43%
3 Months1.561.981.361.67190,646-0.15-9.62%
6 Months2.592.931.331.75303,557-1.18-45.56%
1 Year3.883.951.332.13217,667-2.47-63.66%
3 Years5.509.84651.334.39189,318-4.09-74.36%
5 Years21.0327.731.336.41493,966-19.62-93.30%

Milestone Pharmaceuticals Description

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.

Your Recent History

Delayed Upgrade Clock